Wipro GE Healthcare, GE Healthcare’s business arm in India received the FICCI (Federation of Indian Chambers of Commerce and Industry) Healthcare Excellence Award for its efforts to solve maternal/infant care challenge in India. This recognition from FICCI is for GE Healthcare’s innovations In India, for India to make healthcare affordable and accessible. GE Healthcares Lullaby LED Phototherapy system was chosen as the best innovation by FICCI from amongst 120 innovations from India.
The Lullaby Phototherapy system equips clinicians with a safe, efficient and easy to use tool to deliver high intensity phototherapy to treat infants with hyperbilirubinemia (neonatal jaundice), a condition caused when there is too much bilirubin in the blood. Neonatal jaundice is a widespread problem, occurring in about 60% of term babies and 80% of pre-term infants. If untreated, elevated jaundice has the potential for neurotoxic effects and kernicterus, causing irreversible brain damage. Most common problems of neonatal jaundice can be cured using phototherapy, a shining blue light at the baby. Lullaby LED Phototherapy system utilises LED technology to reduce power consumption as well as overall replacement costs to achieve up to 80 percent energy savings and a 50x extended bulb life, making it one of the most affordable phototherapy system. Lullaby LED Phototherapy system has been developed at the GE India Technology Center.
As per the UN Inter-agency Group for Child Mortality Estimation 2011, almost 30 percent of neo-natal deaths occur in India . The Registrar General’s latest data Sample Registration System 2010 indicates 8.62 lakh child deaths in 2010 within 29 days of life  Premature deaths have also been rampant in India. Globally, the proportion of under-five deaths that occur within the first month of life (the neonatal period) has increased about 10 percent since 1990 to more than 40 percent.
The Award was given by FICCI President, Mr. R V Kanoria and Actor Rahul Bose. The FICCI Healthcare Excellence Awards celebrate the spirit of excellence in India’s health services industry, thereby encouraging initiatives in urban, semi-urban and rural areas to provide accessible and affordable quality healthcare to all.
Expressing her delight over this recognition, Ms. Terri Bresenham, President & CEO, GE Healthcare South Asia said, Care for infants in India is challenged by rising costs, inequality of access and persistent quality issues. The combination of technology, innovations and smarter processes can help doctors and hospitals deliver better healthcare to more people at lower costs. In line with our commitment to make India a healthier nation, we are proud to viable solutions like the Lullaby LED PT. This recognition from FICCI will only reinforce our commitment.
Having recognized India’s healthcare challenges of cost, access and quality, GE Healthcare was the first company to set up manufacturing plants in India to produce high end healthcare imaging products, cost effectively. GE Healthcare has also set up country’s first R&D Centre for designing healthcare solutions In India, for India and employs over 1500 scientists and engineers specifically to develop healthcare solutions. GE Healthcare has rolled out 15 designed In India, for India solutions to accelerate access to healthcare in India. GE Healthcare has received multiple awards from the Government of Karnataka as well as Government of India towards achieving growth and excellence in exporting medical technologies from India. GE Healthcares effort together with East Meets West, a non-governmental organization, to tackle maternal and infant challenges is also acknowledged by WHO in their recent report “ Born too Soon http://www.who.int/pmnch/media/news/2012/borntoosoon_chapter6.pdf.
We are at work for a healthier India. The Lullaby LED Phototherapy System is a great demonstration of our commitment towards lowering costs, improving access and improving clinical quality. Such disruptive technologies can help address a larger vision of meeting Indias millennium development goals (MDG4) to reduce infant mortality, said Munesh Makhija, Chief Technology Officer, GE Healthcare South Asia.